A San Diego biotech hoping to crack into a rare protein misfolding disease has drummed up $130 million in investor support to get into a potential pivotal trial next year. Protego Biopharma, from the …
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
